Results 41 to 50 of about 18,622 (204)

Neurocardiology: Brain–Heart Interactions in the Heart

open access: yesMedComm, Volume 7, Issue 9, September 2026.
The heart and brain maintain systemic homeostasis through bidirectional communication involving neural, biochemical, and mechanical pathways. Dysregulation of these pathways contributes to a spectrum of conditions involving heart–brain interactions, including Takotsubo syndrome, the epileptic heart, stroke–heart syndrome, heart failure, cardiac ...
Wentao Wang   +3 more
wiley   +1 more source

Salvage of ischemic myocardium by dipyridamole in the conscious dog.

open access: yes, 1981
We investigated the effect of i.v. dipyridamole, a potent small-vessel coronary vasodilator, on myocardial infarct size in conscious dogs. Dipyridamole, 7-9.7 microgram/kg; 15 dogs) or saline (15 dogs) was infused for 6 hours beginning 10 minutes after ...
B I Jugdutt   +3 more
core   +1 more source

Dipyridamole for tracking amyloidogenic proteins aggregation and enhancing polyubiquitination

open access: yes, 2022
Dipyridamole is currently used as a medication that inhibits blood clot formation and it is also investigated in the context of neurodegenerative and other amyloid related diseases.
Nadia Licciardello   +20 more
core   +1 more source

The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts

open access: yesBalkan Medical Journal, 2011
Objective: The aim of this study is to evaluate the efficacy of dipyridamole in relieving the vasospasm of coronary artery bypass grafts. Material and Methods: Twenty two patients who underwent elective coronary artery bypass grafting (CABG) were ...
Turan Ege   +5 more
doaj  

Patent Foramen Ovale: Epidemiology, Risk Factors, Pathophysiology, Clinical Features, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 9, September 2026.
The clinical manifestations of PFO. Although the majority of PFOs are benign and asymptomatic, they can present with a variety of clinical manifestations, or coexisting with other diseases and aggravating their symptoms, including cerebral diseases (such as CS, epilepsy, TIA, or migraine), systemic embolism (such as embolism in renal artery, coronary ...
Linlin Meng   +6 more
wiley   +1 more source

Modulation of dipyridamole action by alpha 1 acid glycoprotein. Reduced potentiation of quinazoline antifolate (CB3717) cytotoxicity by dipyridamole.

open access: yes
Dipyridamole potentiates the cytotoxicity of N10-propargyl-5,8-dideazafolic acid (CB3717), an antifolate inhibitor of thymidylate synthase, by inhibiting both thymidine (TdR) salvage and deoxyuridine (UdR) efflux.
Harris AL, Curtin NJ, Newell DR
core   +3 more sources

Effects of Dpyridamole on Histopathology of Salivary Glands in Rabbits [PDF]

open access: yesAl-Rafidain Dental Journal
Aims: Dipyridamole is a well-known coronary vasodilator. It is an adenosine reuptake inhibitor leading to increased blood levels of adenosine. So, this study aims to investigate the effects of systemic administration of dipyridamole on the salivary gland
Abdulsattar S. Mahmood   +2 more
doaj   +1 more source

Clinical and Technical Factors Associated With Tunnelled Central Venous Catheter Dysfunction in Haemodialysis: A Multicentre Session‐Level Retrospective Study

open access: yesNursing Open, Volume 13, Issue 9, September 2026.
ABSTRACT Aim To analyse the clinical, technical, and demographic factors associated with tunnelled central venous catheter dysfunction in patients undergoing haemodialysis. Design Multicentre, retrospective session‐level observational study. Methods We analysed 40,193 haemodialysis sessions from 743 patients with tunnelled central venous catheters ...
Verónica Gimeno Hernán   +7 more
wiley   +1 more source

Molecular Docking Reveals the Potential of Aliskiren, Dipyridamole, Mopidamol, Rosuvastatin, Rolitetracycline and Metamizole to Inhibit COVID-19 Virus Main Protease [PDF]

open access: yes, 2020
Drug repurposing is a fast way to rapidly discover a drug for clinical use. In such circumstances of the spreading of the highly contagious COVID-19, searching for already known drugs is a worldwide demand.
Omar, Aly, Omar Aly (8649477)
core   +1 more source

Dipyridamole Can Augment the Resistance to Parathormone in Chronic Renal Failure

open access: yesTurkish Journal of Nephrology, 2019
Dipyridamole which is used for vasodilatation might enhance renal tubular reabsorption of phosphate. In this study, we aimed to investigate the effect of dipyridamole on Ca, P metabolism, PTH, renal functions and electrolytes in pre-dialysis patients ...
Mustafa BALAL   +4 more
doaj  

Home - About - Disclaimer - Privacy